They also discovered that knock-down of GLS2 expression level inhibited the invasiveness and migration capability of ESCC cells, indicating that GLS2 might be a carcinogenic risk in ESCC [67]. This evidence concerns the gene GLS2 and esophageal squamous cell carcinoma.